Canada: Lessons From GlaxoSmithKline’s Record $492 Million Bribery Fine In China

On September 19, 2014, pharmaceutical giant GlaxoSmithKline plc (GSK) announced that its Chinese subsidiary had been found guilty of bribing health officials in the country and was forced to swallow a 3 billion yuan ($492 million CDN) penalty, the largest corporate fine in China's history. Five of the company's managers were also given suspended prison sentences of two to four years' probation after the one-day trial in Hunan Province. GSK has announced that it is not seeking to appeal.

This bulletin will review what led to GSK's bitter medicine in China's courts and what lessons this example holds for other foreign companies operating in the country or trying to combat their own corruption risks more broadly.

"A Massive Bribery Network"

In June 2013, the Wall Street Journal reported that GSK was investigating allegations from an anonymous tipster that its sales staff engaged in widespread bribery to sell drugs between 2004 and 2010. According to the reports, employees of the company would often treat doctors and others to trips and pay their expenses. Yet after a four-month investigation, GSK announced that its internal probe found no evidence of corruption. Then, in May 2014, Chinese officials launched their own investigation after accusing Mark Reilly, GSK's manager in China, of operating "a massive bribery network" since 2009 by having his salespeople pay doctors and hospital officials bribes to boost GSK's drug sales. According to Chinese officials, these bribes resulted in several billion yuan in "illegal revenue" for the company, an amount commensurate with the fine levied against it. GSK announced it was cooperating with authorities in the investigation, which may account for the probation sentences being more lenient than may have otherwise been expected.

Though it may be too early to say what went wrong for GSK in China, what is known about this case and the corrective actions GSK has since announced it has taken, provide some key lessons for other companies trying to combat their corruption risk.

Understand the Shifting Landscape of Local Compliance Risks

For over 30 years, the United States, through the Foreign Corrupt Practices Act, was effectively the world's anti-corruption police. It was only four years ago that the United Kingdom joined the fray through its tough Bribery Act and Canada finally began to enforce its own Corruption of Foreign Public Officials Act. Yet even then there was often little incentive to comply with local anti-corruption laws in developing countries to the dearth of such prohibitions or their virtual non-enforcement.

This compliance risk is now changing. The fact that the Chinese have now levied a near half billion-dollar corruption fine against a foreign company, even before the Serious Fraud Office in the UK and the Department of Justice in the US concluded their own investigations, changes the risk calculus for corruption in China. Commercial bribery is a crime in China. However, its enforcement has not always been consistent. While there are complaints that some enforcements are selective, there are also reports that several other large pharmaceutical manufacturers are on the list of suspected investigations and have received uninvited visits by Chinese authorities. Foreign companies operating in China in other industries may now find local authorities emboldened to prosecute efforts to seek business advantages through illicit means.

This is also becoming ever more the case in Brazil under the recently enacted (and harsh) Clean Companies Law, in India under the new Lokpal Act and with the newly elected Prime Minister Modi's corruption crackdown, and in many other developing countries instituting and better enforcing their own anti-bribery scheme.

Constantly Monitor Internal Accounting Controls

In announcing its criminal fine, GSK admitted that the illegal activities of its subsidiary were "in clear breach" of its compliance systems and that it was "expanding processes for reviewing and monitoring of invoicing and payments." GSK's response underscores the fact that internal accounting controls are only as effective as a compliance tool to the extent that they are constantly audited through, ideally, a system of sophisticated data analytics and continuous monitoring. GSK would have had some systems in place to track expenditures and, presumably, required proper authorizations and documentation for larger outlays. However, those systems appear to have failed to properly detect potentially hundreds of millions of dollars worth of bribes, gifts and illicit expenses. While no internal control system is perfect, a more sophisticated data review process, tailored to specific red flags for bribes, may have detected problems earlier and avoided such a massive penalty.

Manage Employee Incentive Risk

Sales commissions and salaries tied to specific sales targets are a classic incentive risk for bribery by employees or contractors, especially in higher risk jurisdictions such as China. According to public reports, GSK's management adopted very aggressive sales tactics and incentive mechanisms which influenced the occurrence of the commercial bribes. Similar sales tactics are reported to have been used by some other pharmaceutical companies as well, but GSK was reviewed as one of the worst offenders. It has been reported that the training and remuneration systems of GSK and some other large pharmaceutical manufacturers have been significantly changed to mitigate such issues. Progressive companies have sought to manage these risks in a number of ways, including paying higher salaries to reduce the incentive to bribe, aggregating bonus structures or commissions over a longer period to provide more opportunities for compliance oversight, and providing 'compliance' bonuses.

GSK's problems in China exemplify the importance of properly managing internal employee incentive risk, as does the company's announcement that it is "decoupling sales targets from compensation" for its sales force. Other large pharmaceutical manufacturers are expected to follow suit.

Companies Need Clear Client Engagement Guidelines

Lastly, if reports are true that many of GSK's illicit activities were paid trips and expense reimbursements for doctors and other hospital officials through travel agencies and other intermediaries, this will be just the latest example of a "bribe by any other name." Gifts, entertainment and travel for public officials are prime targets of corruption probes given that anti-bribery legislation in Canada, the UK and US all prohibit the offer of a "benefit" to a public official, which need not be cash, in return for an improper business advantage for the offeror. We have previously provided guidance on gift giving in this context, but all companies should also have clear guidelines on entertainment, hospitality and travel when engaging clients, especially when those clients are public officials. It is also crucial to make sure these guidelines are understood and followed by intermediaries such as agents, consultants and the like.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

In association with
Related Topics
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions